scholarly journals PCN175 BUDGET IMPACT ANALYSIS OF THE INCORPORATION OF MIDOSTAURIN FOR FLT3-POSITIVE ACUTE MYELOID LEUKEMIA (AML) IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM (BPHS).

2019 ◽  
Vol 22 ◽  
pp. S470
Author(s):  
A. Buehler ◽  
H.S.J. Kim ◽  
L. Fahham ◽  
A.L. Matsuo
Keyword(s):  
Acute Myeloid Leukemia ◽  
Healthcare System ◽  
Myeloid Leukemia ◽  
Impact Analysis ◽  
Budget Impact ◽  
Budget Impact Analysis ◽  
Private Healthcare ◽  
Acute Myeloid

Budget impact analysis of CYP2C19 genotyping to guide voriconazole prophylaxis in acute myeloid leukemia (AML).

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. e17777-e17777
Author(s):  
Neil Thomas Mason ◽  
Gillian Casey Bell ◽  
Rod E. Quilitz ◽  
John N. Greene ◽  
Howard L. McLeod
Keyword(s):  
Acute Myeloid Leukemia ◽  
Myeloid Leukemia ◽  
Impact Analysis ◽  
Budget Impact ◽  
Budget Impact Analysis ◽  
Acute Myeloid

scholarly journals Budget Impact Analysis of Gemtuzumab Ozogamicin for the Treatment of CD33-Positive Acute Myeloid Leukemia

2020 ◽  
Vol 39 (1) ◽  
pp. 121-131 ◽  
Author(s):  
Carla Mamolo ◽  
Verna Welch ◽  
Roland B. Walter ◽  
Joseph C. Cappelleri ◽  
James Brockbank ◽  
...  
Keyword(s):  
Acute Myeloid Leukemia ◽  
Myeloid Leukemia ◽  
Impact Analysis ◽  
Budget Impact ◽  
Gemtuzumab Ozogamicin ◽  
Budget Impact Analysis ◽  
Acute Myeloid
Sign in / Sign up

Export Citation Format

Share Document